Variables | Hazard ratio | 95% confidence intervals | P-value |
---|---|---|---|
Pretreatment albumin | Â | Â | Â |
≥35 g/L | 1.00(ref.) |  |  |
<35 g/L | 1.140 | 0.648-2.007 | 0.649 |
Pretreatment CEA a | Â | Â | Â |
<10 ng ml-1 | 1.00(ref.) |  |  |
≥10 ng ml-1 | 1. 900 | 1.056-3.416 | 0.032 |
Differentiation | Â | Â | Â |
Well | 1.00(ref.) | Â | Â |
Moderately | 0. 865 | 0. 323–2.314 | 0.772 |
Low | 1.097 | 0.311-3.871 | 0.885 |
Sex | Â | Â | Â |
Male | 1.00(ref.) | Â | Â |
Female | 0.856 | 0.493-1.489 | 0.583 |
Age | Â | Â | Â |
≤49 years | 1.00(ref.) |  |  |
50-60 yeas | 1.514 | 0.625-3.666 | 0.359 |
>60 years | 1.587 | 0.698-3.607 | 0.271 |
Location | Â | Â | Â |
Rectum | 1.00(ref.) | Â | Â |
Left colon cancer | 1.067 | 0.564-2.019 | 0.843 |
Right colon cancer | 0.647 | 0.296-1.414 | 0.275 |
Stage | Â | Â | Â |
II | 1.00(ref.) | Â | Â |
III | 3.641 | 1.980-6.697 | <0.0001 |
Duration of lymphopenia <1.0 × 10 9 L |  |  |  |
≤28 days | 1.00(ref.) |  |  |
> 28 days | 0.770 | 0.341-1.740 | 0.530 |
Chemotherapy-associated lymphocyte counts | Â | Â | Â |
Lymphocyte counts ≥ 0.66 × 109/L | 1.00(ref.) |  |  |
Lymphopenia <0.66 × 109/L | 2.083 | 1.103-3.936 | 0.024 |